Published in J Biol Chem on April 10, 1974
Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79
Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J Biol Chem (2008) 1.73
Interaction of lipoprotein lipase with heparin-Sepharose. Evaluation of conditions for affinity binding. Biochem J (1977) 1.25
Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets. J Biol Chem (2013) 1.14
The heterogeneity of the lipoprotein lipase of rat epididymal adipose tissue. Biochem J (1978) 1.08
Post-translational regulation of lipoprotein lipase activity in adipose tissue. Biochem J (1978) 1.03
Purification and characterization of lipoprotein lipase from pig myocardium. Biochem J (1975) 0.98
Action of liproprotein lipase on apoprotein-depleted chylomicrons. Biochem J (1978) 0.95
Effects of C apoproteins on the activity of endothelium-bound lipoprotein lipase. Biochem J (1978) 0.94
Effects of glucose and insulin on the activation of lipoprotin lipase and on protein-synthesis in rat adipose tissue. Biochem J (1980) 0.92
Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes. J Clin Invest (1993) 0.91
Purification and characterization of the tween-hydrolyzing esterase of Mycobacterium smegmatis. J Bacteriol (1983) 0.85
Lipoprotein lipase cofactor activity of a carboxyl-terminal peptide of apolipoprotein C-II. Proc Natl Acad Sci U S A (1977) 0.84
Purification and characterization of rat adipose tissue lipoprotein lipase. Biochem J (1982) 0.83
Hydrolysis of plasma triacylglycerol-rich lipoproteins from immature and laying hens (Gallus domesticus) by lipoprotein lipase in vitro. Biochem J (1982) 0.81
Properties of salt-resistant lipase and lipoprotein lipase purified from human post-heparin plasma. Biochem J (1979) 0.80
Hydrolysis of chylomicron triacylglycerol by endothelium-bound lipoprotein lipase. Effect of decreased apoprotein C-II/C-III ratio. Biochem J (1979) 0.80
The characterization of lipoprotein lipase isolated from the post-heparin plasma of the rainbow trout, Salmo gairdneri Richardson. Biochem J (1982) 0.79
Characterization of two triacylglycerol lipase activities in pig post-heparin plasma. Biochem J (1977) 0.78
Transgenic rabbits expressing human lipoprotein lipase. Cytotechnology (2000) 0.76
Assay of proteins in the presence of interfering materials. Anal Biochem (1976) 17.90
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest (1991) 6.50
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A (1984) 6.01
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest (1989) 5.75
Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A (1989) 5.65
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09
Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 4.56
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci U S A (1981) 4.50
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A (1987) 4.10
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A (1987) 3.55
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb (1994) 3.11
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A (1988) 2.83
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis (1983) 2.48
Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb (1994) 2.47
A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem (1989) 2.45
Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest (1986) 2.38
Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest (1991) 2.35
Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis (1986) 2.32
Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1996) 2.32
Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. Proc Natl Acad Sci U S A (1983) 2.25
Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A (1990) 2.23
Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee. Circulation (1982) 2.21
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 2.11
Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J Biol Chem (1982) 2.06
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun (1972) 2.06
Uptake and degradation of low density lipoprotein by swine arterial smoot muscle cells with inhibition of cholesterol biosynthesis. Biochim Biophys Acta (1976) 2.05
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest (1986) 1.96
Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc Natl Acad Sci U S A (1995) 1.95
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol (1997) 1.87
The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med (2000) 1.87
Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J Biol Chem (1985) 1.86
Scavenger receptors, oxidized LDL, and atherosclerosis. Ann N Y Acad Sci (2001) 1.82
Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis (1987) 1.80
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med (1992) 1.77
Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem (1983) 1.77
Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A (1994) 1.76
Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res (1988) 1.76
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med (2001) 1.75
Tissue sites of degradation of low density lipoprotein: application of a method for determining the fate of plasma proteins. Proc Natl Acad Sci U S A (1979) 1.75
Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci U S A (1985) 1.73
Dissecting the role of the golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci U S A (2000) 1.67
The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A (1995) 1.67
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Serum complement and familial combined hyperlipidemia. Atherosclerosis (1997) 1.64
Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc Natl Acad Sci U S A (1987) 1.63
Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry (1999) 1.62
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci U S A (1989) 1.62
Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol (1992) 1.60
Elevated fasting plasma insulin in a general aged population: an innocent companion of cardiovascular diseases. J Am Geriatr Soc (1997) 1.59
Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci U S A (1999) 1.58
Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts. J Clin Invest (1977) 1.58
Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis (1988) 1.57
Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest (1969) 1.56
Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J Clin Invest (1970) 1.56
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 1.55
Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res (1987) 1.54
Radiolabeled sucrose covalently linked to protein. A device for quantifying degradation of plasma proteins catabolized by lysosomal mechanisms. J Biol Chem (1979) 1.54
The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem (2000) 1.54
Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest (1982) 1.53
Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem (1997) 1.53
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A (1995) 1.49
Interactions of plasma lipoproteins with endothelial cells. Ann N Y Acad Sci (1982) 1.46
Lipoproteins and atherosclerosis. A look back and a look ahead. Arteriosclerosis (1983) 1.45
Antioxidant vitamins and coronary heart disease. N Engl J Med (1993) 1.45
Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med (1982) 1.45
Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science (1983) 1.44
Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J (1998) 1.44
Very low density lipoprotein synthesis and secretion by cultured rat hepatocytes. J Biol Chem (1979) 1.44
Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem (1993) 1.43
An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta (1975) 1.43
High-quality filtration allows reuse of anesthesia breathing circuits resulting in cost savings and reduced medical waste. J Clin Anesth (1999) 1.43
A mechanism by which high-density lipoproteins may slow the atherogenic process. Lancet (1976) 1.41
Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation. J Biol Chem (1989) 1.40
The OSBP-related protein family in humans. J Lipid Res (2001) 1.40
Molecular cloning and sequence of a cDNA coding for bovine lipoprotein lipase. Proc Natl Acad Sci U S A (1987) 1.39
Development of a Head Scanner for Proton CT. Nucl Instrum Methods Phys Res A (2012) 1.39
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest (1982) 1.39
Nucleotide sequence of PvuII polymorphic site at the human lipoprotein lipase gene locus. Nucleic Acids Res (1989) 1.38
Firms sleuth out transgenic foods. Nat Biotechnol (1997) 1.38
Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res (1991) 1.36
Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis. J Lipid Res (1998) 1.36
Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes (1982) 1.36
The effect of dietary fat on the turnover of cholic acid and on the composition of the biliary bile acids in man. J Clin Invest (1965) 1.36
Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation (1995) 1.35
Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci U S A (1990) 1.34
Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis (1994) 1.32
Tissue sites of degradation of native and reductively methylated [14C]sucrose-labeled low density lipoprotein in rats. Contribution of receptor-dependent and receptor-independent pathways. J Biol Chem (1982) 1.32